Our jewel of technology: The expansion of Merck’s site | Promove
Home / Relying on regional strengths / Our jewel of technology: The expansion of Merck’s site

Strategic files

Our jewel of technology: The expansion of Merck’s site



Progress report

Merck is one of the world leaders in the pharmacy sector. Merck’s production site, located at Corsier-sur-Vevey (Fenil), is among the largest and most modern biotechnology centers in the world. On this site, Merck produces medicines for multiple sclerosis, some cancers, and carries out clinical trials for several molecules. More than 550 people work there every day. In order to prepare for future growth, the group has been studying for several years where to expand their activity. The site of Fenil, with its exceptional background, appears as the best option for receiving this new jewel of technology.

Aware of the economic impact of this potential investment in the region, all the stakeholders collaborated in making this development possible. Stakeholders include the authorities of Corsier-sur-Vevey, as well as the Service for economic development for the Canton, the intercommunal technical bureau, and local landowners. Several studies concerning the expansion project of the activity centre have been carried out, leading to a partial land use plan (or Plan Partiel d’Affectation, entitled here PPA “En Fenil”).

The process moved forward in March 2019 with the validation of the land use plan by the town council of Corsier-sur-Vevey. After the agreement of the cantonal authorities, the process will continue to the next step: a public inquiry into actual construction projects. The aim is to ensure that Merck settles in the region on a long term basis, creating many jobs.

Promove’s role:

  • LADE financing